Social Biomarker Accountability Governance

Introduction

Social biomarkers are measurable biological indicators that may reflect the effects of social conditions—such as poverty, chronic stress, discrimination, pollution, or social isolation—on human health. Their analysis can support public-health research and help authorities identify communities facing unequal health risks.

However, collecting and interpreting such information creates concerns about privacy, consent, scientific validity, discrimination, and misuse. Social biomarker accountability governance refers to the legal and institutional framework that determines who may collect biomarker data, for what purpose, under what safeguards, and who is responsible when the data or its interpretation causes harm.

In India, this governance is shaped by constitutional rights, data-protection law, medical research ethics, and judicial principles concerning privacy and bodily autonomy. There is no single specialised statute governing every use of social biomarkers.

Governance Principles

A proper accountability framework should contain the following elements:

Informed consent and lawful authority: Research participants should be informed about the purpose, risks, and possible secondary use of their biological data. Any compulsory collection must have a valid legal basis.

Scientific validation: Biomarkers should be tested for reliability and limitations. Correlation with social conditions must not be treated as proof of an individual’s conduct or character.

Purpose limitation: Data collected for health research should not automatically be reused for employment screening, insurance profiling, policing, or welfare eligibility.

Privacy and security: Identifiable data should be minimised, protected through access controls and encryption, and retained only as required.

Fairness and non-discrimination: Institutions should assess whether biomarker-based systems unfairly disadvantage poor, marginalised, or historically over-monitored communities.

Independent oversight and remedies: Ethics committees, regulators, and courts should be able to review misuse, while affected persons should have access to complaint mechanisms and legal remedies.

The Digital Personal Data Protection Act, 2023 provides a statutory framework for digital personal data processing. Its applicability to a particular biomarker project depends on whether the information is personal data, how it is processed, and the relevant commencement and statutory provisions.

IndiaCode+1

Important Case Laws

1. Justice K.S. Puttaswamy (Retd.) v. Union of India, (2017) 10 SCC 1

The Supreme Court recognised privacy as a fundamental right under Article 21 and other constitutional freedoms. It established that State interference with privacy must satisfy legality, legitimate purpose, and proportionality.

This judgment is central to social biomarker governance. Collection of identifiable biological data must be justified, necessary, and protected against unauthorised use.

Indian Kanoon+1

2. Puttaswamy v. Union of India (Aadhaar), (2019) 1 SCC 1

The Court examined the collection and linkage of biometric and identity information. It recognised the importance of limiting data use to legitimate purposes and protecting against unauthorised disclosure or extraneous use.

The reasoning is relevant where biomarker information is linked to welfare, employment, insurance, or health databases. Such linkage may enable profiling and requires careful safeguards.

Indian Kanoon

3. Selvi v. State of Karnataka, (2010) 7 SCC 263

The Supreme Court held that involuntary narco-analysis, polygraph examination, and brain electrical activation profile tests violated constitutional protections, including Article 21 and, in relevant circumstances, Article 20(3).

Although the case did not concern social biomarkers, it supports the principle that scientific testing cannot override bodily autonomy and constitutional rights. Compulsory biomarker testing therefore requires strict scrutiny of consent and legal authority.

Indian Kanoon

Conclusion

Social Biomarker Accountability Governance is an emerging field, not a separately codified Indian legal doctrine. Its foundations lie in constitutional privacy, equality, data-protection obligations, research ethics, and civil liability.

The above judgments support a governance system based on lawful collection, scientific reliability, limited use, privacy safeguards, independent oversight, and effective remedies. Social biomarker technology should assist public-health research and policy without becoming a tool for arbitrary profiling, discrimination, or exclusion.